Streetbeat News

FUJIY

Fujifilm Holdings Corp.

https://www.fujifilmholdings.com/ja/

CEO

Shigetaka Komori

Open

10.26

Mkt cap

25B

Volume

117K

High

10.40

P/E Ratio

51.90

52-wk high

13.88

Low

10.26

Div yield

0.02

52-wk low

9.52

Fujifilm has announced eight new recipients of its fellowships at Harvard Medical School, as part of a multi-year program aimed at advancing translational medical science research and education.

Portfolio Pulse from

January 09, 2025 | 1:15 pm

FUJIFILM is expanding its health screening services by opening the NURA Global Innovation Center in India. This center will focus on health screenings, medical staff training, and remote image analysis, enhancing FUJIFILM's global health initiatives.

Portfolio Pulse from

December 24, 2024 | 2:00 pm

Fujifilm has been granted authority to operate its ASPIRE Cristalle Acquisition Workflow System on U.S. Department of Defense networks, allowing secure access to mammography images.

Portfolio Pulse from

December 16, 2024 | 1:00 pm

Fujifilm is set to unveil new medical innovations at the RSNA 2024 Conference, focusing on advanced imaging technologies that enhance clinical workflows and patient outcomes.

Portfolio Pulse from

November 27, 2024 | 1:00 pm

FUJIFILM Diosynth Biotechnologies has completed the expansion of its California cell therapy facility and received EMA GMP certification.

Portfolio Pulse from

November 20, 2024 | 10:00 pm

FUJIFILM Healthcare Europe has launched the next stage of DeepInsight, an innovative ultrasound technology aimed at improving early diagnosis and treatment. This advancement is expected to benefit imaging professionals by enhancing accuracy and follow-up management.

Portfolio Pulse from

November 09, 2024 | 9:15 am

FUJIFILM reported a decline in earnings for Q2, but revenues increased year-over-year due to strong sales in the Imaging and Electronics segments and favorable exchange rates.

Portfolio Pulse from

November 07, 2024 | 5:45 pm

FUJIFILM Diosynth Biotechnologies has announced the launch of the first phase of its global CDMO ecosystem expansion, focusing on a modular network for facility design and drug production.

Portfolio Pulse from

November 05, 2024 | 12:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.